Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection
NCT06401720 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2024-05-07
Summary
The goal of this observational study is to understand immune responses to viral airway infection in adults, including the elderly. The main question(s) to answer is/are:
Why do some individuals acquire only asymptomatic or mild Influenza A virus (IAV) infection while others become severely ill and even succumb to the same disease?
Participants will be asked to donate samples when seeking health care for influenza-like symptoms or if hospitalized for IAV or SARS-CoV-2. Samples asked for are:
* Blood sample by venepuncture
* Blood sample by capillary sampling
* Nasopharyngeal aspirate
* Nasopharyngeal swab
* Endotracheal tube aspirate
* Nasal swab
* Nasal curette
* Breath Explor (sampling of expired air)
Researchers will compare obtained results with the same type of samples from healthy controls.
Conditions
- Influenza A Infection
- Influenza B Virus Infection
- SARS CoV 2 Infection
- RSV Infection
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Anna Smed Sörensen, PhD · Karolinska Institutet
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2028-12-31
- Completion
- 2030-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
NCT04664075 ·Status: TERMINATED
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
T-cell Response-Flu Risk in Older Adults
NCT00138398 ·Status: COMPLETED ·Phase: NA
-
Systems Investigation of Vaccine Responses in Aging and Frailty
NCT05291676 ·Status: RECRUITING ·Phase: PHASE2
-
Th1 Response to Influenza: Aging and Vaccine Efficacy
NCT00396305 ·Status: TERMINATED ·Phase: PHASE4
-
The Immune Response to Influenza Vaccinations in Elderly Individuals
NCT03266237 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
NCT02037282 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
NCT00938392 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
NCT00753272 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza in People With Normal and Weakened Immune Systems
NCT00533182 ·Status: COMPLETED
-
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above
NCT01880697 ·Status: COMPLETED ·Phase: PHASE3
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects
NCT01459276 ·Status: COMPLETED ·Phase: NA
-
Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years
NCT01289535 ·Status: UNKNOWN ·Phase: PHASE4
-
Influenza Vaccination Among the Elderly Individuals
NCT02362919 ·Status: COMPLETED
-
A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults
NCT05823974 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People
NCT00992784 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
NCT02297542 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults
NCT01626820 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly
NCT00391053 ·Status: COMPLETED ·Phase: PHASE3
-
Cell Mediated Immunity in Older Adults
NCT01189123 ·Status: COMPLETED ·Phase: NA
-
Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons
NCT01404182 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.
NCT02101749 ·Status: COMPLETED ·Phase: PHASE4
-
The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine
NCT02269852 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People
NCT01408290 ·Status: COMPLETED ·Phase: NA